Literature DB >> 1283786

Prenatal detection of 45,X/46,XX/47,XXX mosaicism through amniocentesis: mosaicism confirmed in cord blood, amnion, and chorion.

S Schwartz1, L J Raffel.   

Abstract

Sex chromosome mosaicism in amniotic fluid cells poses a serious dilemma in prenatal diagnosis. Chromosome analysis of 56 primary clones of amniocytes revealed three distinct cell lines. Nine cells (16.1 per cent) demonstrated a 45,X karyotype, 11 cells (19.6 per cent) a 47,XXX karyotype, and the remaining 36 cells (64.3 per cent) had a modal number of 46 chromosomes (46,XX). Cytogenetic evaluation of 100 cells from cord blood, amnion, and chorion following delivery confirmed this triple mosaicism. However, the distribution of the three karyotypes in the pre- and postnatal samples was not found in the same proportions. The cord blood had the most similar frequency to that of the amniotic fluid sample, while the chorion had a significantly increased frequency of 47,XXX cells (41 per cent) and a decreased frequency of 45,X cells (2 per cent). Physical examination of the infant at birth revealed no discernible phenotypic abnormalities. Parental karyotypes were normal. This case highlights the difficulty in determining whether a prenatally detected abnormality will be associated with postnatal phenotypic deviation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1283786     DOI: 10.1002/pd.1970121210

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  2 in total

1.  Incidental prenatal diagnosis of sex chromosome aneuploidies: health, behavior, and fertility.

Authors:  J J P M Pieters; A J A Kooper; A Geurts van Kessel; D D M Braat; A P T Smits
Journal:  ISRN Obstet Gynecol       Date:  2011-12-12

2.  Prenatally Diagnosed Rare Trisomy 16 Mosaicism in Human Amniotic Fluid Cells in the Second Trimester: A Case Report.

Authors:  Sook Ryung Kim; Eun Jung Choi; Young Joo Kim; Tae Yoon Kim; Young Jin Lee
Journal:  Dev Reprod       Date:  2018-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.